Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke

Fig. 8

In vivo biocompatibility of RGD-PLT@PLGA-FE. A H&E staining of main organs including brain, lung, liver, spleen, kidney in 10% sucrose and RGD-PLT@PLGA-FE treated mice. Scale Bar = 100 μm. n = 5/group. B H&E staining of main organs including brain, lung, liver, spleen, kidney in 10% sucrose and RGD-PLT@PLGA-FE treated mice. Scale Bar = 50 μm. n = 5/group. C Quantitative analysis of blood routine tests in 10% sucrose and RGD-PLT@PLGA-FE treated mice. n = 5/group. D The analysis of serum blood chemistry test in 10% sucrose and RGD-PLT@PLGA-FE treated mice. n = 5/group. Data presented as mean ± SD

Back to article page